IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 115

Article Submitted : 19450

Article Published : 8041

Total Authors : 21252

Total Reviewer : 769

Total Countries : 144

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: A Review Article on Artificial Intelligence in Pharmaceutical Industry & Healthcare
Authors Name: GURU PRASAD GUPTA , PIYUSH SINGH , SWAPNA SAHU , KIRAN SINGH
Download E-Certificate: Download
Author Reg. ID:
IJRTI_188601
Published Paper Id: IJRTI2312014
Published In: Volume 8 Issue 12, December-2023
DOI:
Abstract: Your comprehensive description highlights the multifaceted applications of Artificial Intelligence (AI) across various fields, particularly in the pharmaceutical sector. The role of AI in medication discovery, development for complex diseases, drug adherence, dose optimization, and drug production underscore its versatility and impact on healthcare. The mention of the challenges in the clinical trial process and the potential of AI to streamline tasks like patient selection and enrolment is crucial for improving efficiency and addressing issues like the low completion rate of clinical trials. However, your observation about the limited evidence of AI use in clinical trials aligns with the ongoing exploration and adoption of these technologies in the pharmaceutical industry. The integration of AI in clinical trials holds promise for advancing research and improving patient outcomes.
Keywords: artificial intelligence, r & d, drug discovery, machine learning.
Cite Article: "A Review Article on Artificial Intelligence in Pharmaceutical Industry & Healthcare", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 12, page no.89 - 99, December-2023, Available :http://www.ijrti.org/papers/IJRTI2312014.pdf
Downloads: 000205155
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2312014
Registration ID:188601
Published In: Volume 8 Issue 12, December-2023
DOI (Digital Object Identifier):
Page No: 89 - 99
Country: JAUNPUR, UTTAR PRADESH, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2312014
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2312014
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner